Skip to main content
Bio Solution Co.,Ltd. logo

Bio Solution Co.,Ltd. — Investor Relations & Filings

Ticker · 086820 ISIN · KR7086820008 KO Manufacturing
Open in API
Filings indexed 214 across all filing types
Latest filing 2020-02-28 Major Shareholding Noti…
Country KR South Korea
Listing KO 086820

About Bio Solution Co.,Ltd.

https://bio-solution.co.kr/

Bio Solution Co., Ltd. is a biotechnology company focused on the development, manufacturing, and sale of cell therapy products. The company's core activities involve cell-based biotechnology, producing therapeutics such as autologous chondrocyte treatments for cartilage regeneration. In addition to its therapeutic offerings, Bio Solution develops human tissue models and provides alternative testing solutions. The company also manufactures and distributes a portfolio of bio-laboratory products, including ready-to-use kits, staining solutions, and various reagents for molecular biology research and development applications.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (directors/executives) due to the exercise of stock options. This type of filing is categorized as a 'Major Shareholding Notification' (MRQ) as it tracks significant ownership changes and threshold reporting.
2020-02-28 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (BioSolution) announcing a significant change (over 30%) in revenue or profit structure. This type of disclosure is a standard regulatory requirement in the Korean market (DART system) for material financial changes. It provides key financial highlights and reasons for the variance, which fits the definition of an Earnings Release (ER) as it is an initial announcement of financial results/performance changes rather than a full annual report or a simple report publication notice. FY 2019
2020-02-07 Korean
기타경영사항(특허권취득)(자율공시)(구슬형 연골세포 치료제의 제조방법)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent for a bead-type chondrocyte therapeutic manufacturing method. It does not fit into specific categories like financial reports, board changes, or share transactions. As it is a regulatory announcement of a corporate event (patent acquisition) that does not fall into the other specific categories, it is classified as a general regulatory filing.
2020-02-04 Korean
대표이사변경
Board/Management Information Classification · 1% confidence The document is a formal announcement regarding the change of the CEO (Representative Director) of the company BioSolution. It details the previous CEOs, the new CEO, the reason for the change, and the date of the board resolution. This falls directly under the category of board/management changes.
2020-01-14 Korean
단일판매ㆍ공급계약체결
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory announcement regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) between BioSolution and Mundipharma. It details the contract value, duration, and terms. Since this is a specific regulatory disclosure of a material business event (a contract win) that does not fit into the other specific categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2020-01-07 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the suspension of share registration (shareholder register closure) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or financial statements, but rather serves as a formal notice of a corporate action. As it does not fit into specific categories like dividend announcements or share buybacks, it is classified as a general regulatory filing.
2019-12-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.